How to Optimize Therapeutic Ratio in Brachytherapy of Head and Neck Squamous Cell Carcinoma?

Author： Mazeron Jean-Jacques   Gerbaulet Alain   Simon Jean-Marc   Hardiman Claire  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.37, Iss.6, 1998-11, pp. : 583-591

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene profiling in squamous cell carcinoma of the head and neck

By Akervall Jan  

Cancer and Metastasis Reviews, Vol. 24, Iss. 1, 2005-01 ,pp. : 87-94

Springer Publishing Company

Access to resources Recommend Favorite

Cetuximab in squamous cell carcinoma of the head and neck

By Hitt Ricardo   Martín Patricia   Hidalgo Manuel  

Future Oncology, Vol. 2, Iss. 4, 2006-08 ,pp. : 449-457

Future Medicine

Access to resources Recommend Favorite

Unknown Primary Squamous Cell Carcinoma of the Head and Neck

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 167-174

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck

By Hoffmann Thomas   Bier Henning   Whiteside Theresa  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 12, 2004-12 ,pp. : 1055-1067

Springer Publishing Company

Access to resources Recommend Favorite

Retinoic Acid Concentrations in Patients With Squamous Cell Carcinoma of the Head and Neck

By Wahlberg P.   Fex G.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 366-367

Elsevier

Access to resources Recommend Favorite